332 related articles for article (PubMed ID: 22394286)
1. Telomerase deficiency does not alter bleomycin-induced fibrosis in mice.
Degryse AL; Xu XC; Newman JL; Mitchell DB; Tanjore H; Polosukhin VV; Jones BR; McMahon FB; Gleaves LA; Phillips JA; Cogan JD; Blackwell TS; Lawson WE
Exp Lung Res; 2012 Apr; 38(3):124-34. PubMed ID: 22394286
[TBL] [Abstract][Full Text] [Related]
2. Telomerase and telomere length in pulmonary fibrosis.
Liu T; Ullenbruch M; Young Choi Y; Yu H; Ding L; Xaubet A; Pereda J; Feghali-Bostwick CA; Bitterman PB; Henke CA; Pardo A; Selman M; Phan SH
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):260-8. PubMed ID: 23526226
[TBL] [Abstract][Full Text] [Related]
3. Intratracheal bleomycin causes airway remodeling and airflow obstruction in mice.
Polosukhin VV; Degryse AL; Newcomb DC; Jones BR; Ware LB; Lee JW; Loyd JE; Blackwell TS; Lawson WE
Exp Lung Res; 2012 Apr; 38(3):135-46. PubMed ID: 22394287
[TBL] [Abstract][Full Text] [Related]
4. KLF4 regulates TERT expression in alveolar epithelial cells in pulmonary fibrosis.
Wang H; Xu H; Lyu W; Xu Q; Fan S; Chen H; Wang D; Chen J; Dai J
Cell Death Dis; 2022 May; 13(5):435. PubMed ID: 35508454
[TBL] [Abstract][Full Text] [Related]
5. Telomerase reverse transcriptase ameliorates lung fibrosis by protecting alveolar epithelial cells against senescence.
Liu T; Gonzalez De Los Santos F; Zhao Y; Wu Z; Rinke AE; Kim KK; Phan SH
J Biol Chem; 2019 May; 294(22):8861-8871. PubMed ID: 31000627
[TBL] [Abstract][Full Text] [Related]
6. Lung alveolar integrity is compromised by telomere shortening in telomerase-null mice.
Lee J; Reddy R; Barsky L; Scholes J; Chen H; Shi W; Driscoll B
Am J Physiol Lung Cell Mol Physiol; 2009 Jan; 296(1):L57-70. PubMed ID: 18952756
[TBL] [Abstract][Full Text] [Related]
7. Telomere shortening activates TGF-β/Smads signaling in lungs and enhances both lipopolysaccharide and bleomycin-induced pulmonary fibrosis.
Liu YY; Shi Y; Liu Y; Pan XH; Zhang KX
Acta Pharmacol Sin; 2018 Nov; 39(11):1735-1745. PubMed ID: 29925920
[TBL] [Abstract][Full Text] [Related]
8. Telomerase gene mutations and telomere length shortening in patients with idiopathic pulmonary fibrosis in a Chinese population.
Dai J; Cai H; Zhuang Y; Wu Y; Min H; Li J; Shi Y; Gao Q; Yi L
Respirology; 2015 Jan; 20(1):122-8. PubMed ID: 25346280
[TBL] [Abstract][Full Text] [Related]
9. Telomerase treatment prevents lung profibrotic pathologies associated with physiological aging.
Piñeiro-Hermida S; Autilio C; Martínez P; Bosch F; Pérez-Gil J; Blasco MA
J Cell Biol; 2020 Oct; 219(10):. PubMed ID: 32777016
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity is required for bleomycin-induced pulmonary fibrosis in mice.
Liu T; Chung MJ; Ullenbruch M; Yu H; Jin H; Hu B; Choi YY; Ishikawa F; Phan SH
J Clin Invest; 2007 Dec; 117(12):3800-9. PubMed ID: 18008008
[TBL] [Abstract][Full Text] [Related]
11. Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations.
Diaz de Leon A; Cronkhite JT; Katzenstein AL; Godwin JD; Raghu G; Glazer CS; Rosenblatt RL; Girod CE; Garrity ER; Xing C; Garcia CK
PLoS One; 2010 May; 5(5):e10680. PubMed ID: 20502709
[TBL] [Abstract][Full Text] [Related]
12. Telomere shortening in familial and sporadic pulmonary fibrosis.
Cronkhite JT; Xing C; Raghu G; Chin KM; Torres F; Rosenblatt RL; Garcia CK
Am J Respir Crit Care Med; 2008 Oct; 178(7):729-37. PubMed ID: 18635888
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis.
Borie R; Tabèze L; Thabut G; Nunes H; Cottin V; Marchand-Adam S; Prevot G; Tazi A; Cadranel J; Mal H; Wemeau-Stervinou L; Bergeron Lafaurie A; Israel-Biet D; Picard C; Reynaud Gaubert M; Jouneau S; Naccache JM; Mankikian J; Ménard C; Cordier JF; Valeyre D; Reocreux M; Grandchamp B; Revy P; Kannengiesser C; Crestani B
Eur Respir J; 2016 Dec; 48(6):1721-1731. PubMed ID: 27836952
[TBL] [Abstract][Full Text] [Related]
14. Telomerase Deficiency Causes Alveolar Stem Cell Senescence-associated Low-grade Inflammation in Lungs.
Chen R; Zhang K; Chen H; Zhao X; Wang J; Li L; Cong Y; Ju Z; Xu D; Williams BR; Jia J; Liu JP
J Biol Chem; 2015 Dec; 290(52):30813-29. PubMed ID: 26518879
[TBL] [Abstract][Full Text] [Related]
15. Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis.
Degryse AL; Tanjore H; Xu XC; Polosukhin VV; Jones BR; McMahon FB; Gleaves LA; Blackwell TS; Lawson WE
Am J Physiol Lung Cell Mol Physiol; 2010 Oct; 299(4):L442-52. PubMed ID: 20562227
[TBL] [Abstract][Full Text] [Related]
16. Investigation of telomere related gene mutations in idiopathic pulmonary fibrosis.
Yildirim H; Yildiz P; Coskunpinar E
Mol Biol Rep; 2020 Oct; 47(10):7851-7860. PubMed ID: 33006015
[TBL] [Abstract][Full Text] [Related]
17. Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis.
Kropski JA; Lawson WE; Young LR; Blackwell TS
Dis Model Mech; 2013 Jan; 6(1):9-17. PubMed ID: 23268535
[TBL] [Abstract][Full Text] [Related]
18. From organ to cell: Multi-level telomere length assessment in patients with idiopathic pulmonary fibrosis.
van Batenburg AA; Kazemier KM; van Oosterhout MFM; van der Vis JJ; van Es HW; Grutters JC; Goldschmeding R; van Moorsel CHM
PLoS One; 2020; 15(1):e0226785. PubMed ID: 31910222
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic pulmonary fibrosis: update on genetic discoveries.
Garcia CK
Proc Am Thorac Soc; 2011 May; 8(2):158-62. PubMed ID: 21543794
[TBL] [Abstract][Full Text] [Related]
20. A novel telomerase activator suppresses lung damage in a murine model of idiopathic pulmonary fibrosis.
Le Saux CJ; Davy P; Brampton C; Ahuja SS; Fauce S; Shivshankar P; Nguyen H; Ramaseshan M; Tressler R; Pirot Z; Harley CB; Allsopp R
PLoS One; 2013; 8(3):e58423. PubMed ID: 23516479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
